Job ID: 628587
Job date: 2017-11-06
End Date:
Company : Institute of Cancer Research (ICR) Country : Role : Other
Job date: 2017-11-06
End Date:
Company : Institute of Cancer Research (ICR) Country : Role : Other
Job Description:
OBJECTIVE OF THE POST: The role focuses on the development and provision of broad, state-of-the art bioinformatics and biostatistics analysis to support drug discovery and will involve both applying bioinformatics and the development of pipelines to support these. The post holder will be embedded within the world-leading Cancer Research UK Cancer Therapeutics Unit and exposed to, and contribute to, all aspects of drug discovery and will be responsible for supporting specific drug discovery projects that cover the thematic areas described above. We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff…
Additional Info:
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer. The Cancer Research UK Cancer Therapeutics Unit (CTU) is a major component of the Division of Cancer Therapeutics at The Institute of Cancer Research (ICR), and is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. We are one of the largest academic cancer drug discovery group in the world and, since 2010, 9 drugs discovered by CTU scientists, either alone or in collaboration with a commercial partner, have been studied in our ICR/Royal Marsden Drug Development Unit. Our drug abiraterone has been approved in the US, Canada and Europe for late stage prostate cancer. [Click Here to Access the Original Job Post]
OBJECTIVE OF THE POST: The role focuses on the development and provision of broad, state-of-the art bioinformatics and biostatistics analysis to support drug discovery and will involve both applying bioinformatics and the development of pipelines to support these. The post holder will be embedded within the world-leading Cancer Research UK Cancer Therapeutics Unit and exposed to, and contribute to, all aspects of drug discovery and will be responsible for supporting specific drug discovery projects that cover the thematic areas described above. We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff…
Skills :
Areas :
Additional Info:
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment. Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally. The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer. The Cancer Research UK Cancer Therapeutics Unit (CTU) is a major component of the Division of Cancer Therapeutics at The Institute of Cancer Research (ICR), and is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. We are one of the largest academic cancer drug discovery group in the world and, since 2010, 9 drugs discovered by CTU scientists, either alone or in collaboration with a commercial partner, have been studied in our ICR/Royal Marsden Drug Development Unit. Our drug abiraterone has been approved in the US, Canada and Europe for late stage prostate cancer. [Click Here to Access the Original Job Post]